Favorable WSJ article on new AZ drug

 Favorable WSJ article on New AZ drug link

Very optimistic article.  

Could it be a pro-business article? Helping Big Pharma?

With my neurologist we decided to hold off on new drug 

(since I was heterozygous w Apoe4 gene) for 6 months. 

I read  TATTOO ON MY BRAIN by a neurologist who was dx w AZ 5 years ago.

He had an ARIA reaction to the drug and ended up in the ICU. 

With high dose steroids he recovered.  

Ripping off the amyloid in a patient that is homozygous positive ApoE4 caused inflammation and microhemorrhages.

He had a bad decline with his AZ..

However  with high dose steroids he recovered and seemed to be better mentally than before.

Perhaps this is a way to approach treating AZ.  Get a strong reaction to the drug then decrease inflammation with high dose steroids.  

Kudos to Dr Daniel Gibbs for publishing this idea in his book.